Kappa opioid receptor-induced aversion requires p38 MAPK activation in VTA dopamine neurons JM Ehrich, DI Messinger, CR Knakal, JR Kuhar, SS Schattauer, ... Journal of Neuroscience 35 (37), 12917-12931, 2015 | 179 | 2015 |
Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor SS Schattauer, JR Kuhar, A Song, C Chavkin Cellular signalling 32, 59-65, 2017 | 94 | 2017 |
Ligand directed signaling differences between rodent and human κ-opioid receptors SS Schattauer, M Miyatake, H Shankar, C Zietz, JR Levin, LY Liu-Chen, ... Journal of Biological Chemistry 287 (50), 41595-41607, 2012 | 53 | 2012 |
Mu opioid receptor stimulation activates c-Jun N-terminal kinase 2 by distinct arrestin-dependent and independent mechanisms JR Kuhar, A Bedini, EJ Melief, YC Chiu, HN Striegel, C Chavkin Cellular signalling 27 (9), 1799-1806, 2015 | 47 | 2015 |
Peroxiredoxin 6 mediates Gαi protein-coupled receptor inactivation by cJun kinase SS Schattauer, BB Land, KL Reichard, AD Abraham, LM Burgeno, ... Nature communications 8 (1), 743, 2017 | 39 | 2017 |
Reduction in delayed mortality and subtle improvement in retrograde memory performance in pilocarpine‐treated mice with conditional neuronal deletion of cyclooxygenase‐2 gene JR Levin, G Serrano, R Dingledine Epilepsia 53 (8), 1411-1420, 2012 | 37 | 2012 |
Arrestin-mediated activation of p38 MAPK: molecular mechanisms and behavioral consequences C Chavkin, SS Schattauer, JR Levin Arrestins-Pharmacology and Therapeutic Potential, 281-292, 2014 | 28 | 2014 |
Opioid Receptor Activation Recruits PRDX6 and Depalmitoylates Gai to Block Signaling C Chavkin, S Schattauer, J Kuhar, SE Ong NEUROPSYCHOPHARMACOLOGY 41, S617-S618, 2016 | | 2016 |
Mechanisms of Opioid Receptor Desensitization JR Kuhar | | 2015 |